You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR ODEVIXIBAT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ODEVIXIBAT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04336722 ↗	Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)	Recruiting	Albireo	Phase 3	2020-07-10	Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.
NCT04674761 ↗	Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome	Recruiting	Albireo	Phase 3	2021-03-19	Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in Patients with Alagille Syndrome.
NCT05035030 ↗	Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome	Enrolling by invitation	Albireo	Phase 3	2021-09-03	An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT-EXT)
NCT05426733 ↗	An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia	Enrolling by invitation	Albireo	Phase 3	2022-07-01	An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ODEVIXIBAT

Condition Name

Chart
Table

Condition Name for ODEVIXIBAT
Intervention	Trials
Alagille Syndrome	2
Biliary Atresia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ODEVIXIBAT
Intervention	Trials
Syndrome	2
Alagille Syndrome	2
Biliary Atresia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ODEVIXIBAT

Trials by Country

Map
Table

Trials by Country for ODEVIXIBAT
Location	Trials
United States	28
Belgium	2
Germany	2
Italy	2
Netherlands	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ODEVIXIBAT
Location	Trials
New York	4
California	3
Pennsylvania	2
Oregon	2
Missouri	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ODEVIXIBAT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ODEVIXIBAT
Clinical Trial Phase	Trials
Phase 3	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ODEVIXIBAT
Clinical Trial Phase	Trials
Enrolling by invitation	2
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ODEVIXIBAT

Sponsor Name

Chart
Table

Sponsor Name for ODEVIXIBAT
Sponsor	Trials
Albireo	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ODEVIXIBAT
Sponsor	Trials
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.